While directionally correct, DGA 2025-2030 gives off misleading signals for patients at risk for steatotic liver disease, especially regarding protein intake and alcohol use.

Nearly a decade ago, a landmark trial of deep brain stimulation for depression failed to show efficacy. Now researchers are ...

When added to semaglutide or placebo, glucose-dependent insulinotropic polypeptide (GIP) shows no effect on glycemic control ...

Propofol infusion may not offer better 30-day recovery or survival outcomes after major noncardiac surgery compared with ...

Olezarsen now covers severe hypertriglyceridemia; plozasiran remains FCS-only. Neha Pagidipati, MD, on what the split means for practice.

About one1 in five5 patients with adrenal incidentalomas hadve changes in cortisol status over time, suggesting that routine ...

A ‘living’ evidence review of bipolar disorder treatments has been transformed into a free, continuously updated online tool ...

An analysis using data from three long-running studies on the effect of lifestyle and health provides more support for ...

Hyponatraemia during the first 72 hours of life is linked to later neurodevelopmental disorders or death in infants with ...

Opioid use disorder is associated with a higher risk for complications before discharge after inpatient removal of the uterus ...

Ankle strength shows no clear association with foot posture or general joint hypermobility in children, with only weak links ...

Many adults on GLP-1s maintain their weight loss at 2 years. Full return to baseline weight is found to be rare.